Fast response hydrogen gas sensor based on Pd/Cr nanogaps fabricated by a single-step bending deformation.

The development of low-cost and high performing hydrogen gas sensors is important across many sectors, including mining, energy and defense using hydrogen (H2) gas. Herein, we demonstrate a new concept of H2 sensors based on Pd/Cr nanogaps created by using a simple mechanical bending deformation technique. These nanogap sensors can selectively detect the H2 gas based on transduction of the volume expansion after H2 uptake into an electrical signal by palladium-based metal-hydrides that allows closure of nanogaps for electrons flowing or tunneling. While this break-junction architecture, according to literature, can provide several advantages with research gaps in terms of fabricating nanogap sensors with ultra-fast response (≤4 s), the size of nanogap (≤20 nm) and their relationship with time response and recovery as addressed in this paper. Based on the computational modelling outcome, the size of the nanogaps can be investigated in order to optimize the fabrication conditions. Indeed, a single nanogap with optimum width (15 nm) acts as an on-off switch for best performing hydrogen detection. Moreover, with the unique design of Pd/Cr nanogap, the developed sensing device meets major requirement of advanced H2 gas sensor including room temperature (25 °C) operation, detection of trace amounts (10-40,000 ppm), good linearity, ultra-fast response-recovery time (3/4.5 s) and high selectivity. The presented economical lithography-free fabrication method has simple circuitry, low power consumption, recyclability, and favorable aging properties that promises great potential to be used for many practical applications of H2 detection.

Hyperglycaemia and vitamin D: a systematic overview.

Vitamin D plays a role in a range of functions that may impact on glycaemic control. In this study we systematically report on clinical studies evaluating the impact of vitamin D on aspects of hyperglycaemia in non-pregnant adults. A total of 1,294 articles, of which 417 were reviews, were identified. No well-designed randomised, controlled trials were identified that specifically investigated the effects of vitamin D supplementation on glucose and insulin concentrations. The majority of the studies that are available were poorly designed, having limited numbers, short study duration, or were conducted in volunteers with normal baseline, as measured by 25-hydroxyvitamin D (25(OH)D), concentrations or used inadequate doses of the supplements to normalise vitamin D concentrations, or used inappropriate analyses. Most studies did not observe improvements in glycaemia, with few exceptions. The results were more equivocal for aspects of insulin resistance. Most found no benefit on measures of insulin resistance, although some did. However, more studies described improved insulin release, although data from the studies to date are really inadequate to provide any reliable conclusions. Well-conducted randomised, controlled trials with adequate vitamin D doses are required to effectively assess whether this vitamin can reduce the incidence of diabetes.